🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excelente conferencia del Andres Daniele in Esc Cardio-oncology congress iLACO International Cardio-Oncology Society European Society of Cardiology

Cómo ILACO Nos place compartir a través de nuestras redes sociales la presencia y participación de nuestros miembros en el primer congreso de Cardio oncología de la sociedad europea de cardiología en Florencia Italia. Felicitamos a #ESCardioOnc2025 #ILACO

Assessing the Severity and Risks of ICI-Associated Myocarditis: Key Clinical Indicators in #EHJ! academic.oup.com/eurheartj/adva… #EHJ #cardiotwitter #myocarditis #oncology @ESC_journals European Society of Cardiology

#ESCardioOnco2025 has come to an end. 880 attendees, 2 days full of activities, dozens of research studies presented and tons of time to meet old friends and make new ones. The bad news: the conference has finished, the good news: this was the first of many more to come!!

Didn't you have enough from the recent ESC Congress on #CardioOncology! The you certainly need to check the new European Society of Cardiology Journals collection for the latest updates! #OpenUpYourScience with #EHJOpen!

Heart disease is still the #1 killer in the United States, but it's no longer from heart attacks...instead it's from heart failure and arrhythmias ahajournals.org/doi/10.1161/JA…

The European Society of Cardiology Journals Family will have a new addition at the beginning of 2026 – the European Heart Journal - Cardio-Oncology. This exciting new publication will need an Editor-in-Chief – and we will soon be announcing the call for applications. If you want to receive updates, make

ICYMI: Pre-existing #HeartFailure in older patients with newly diagnosed HL is common & assoc. with higher 1-year mortality. Strategies are needed to improve #lymphoma & CV outcomes in this high-risk population. jacc.org/doi/10.1016/j.… #JACCCardioOnc #CardioOnc #lymsm #cvGeri

📣 Join us for a special #CardioOncology Networking Event in Madrid! 🇪🇸 Hosted by CardioOncologia SEC , in collaboration with European Society of Cardiology @ic_os 📅 31 August 2025 📍 Reina Sofía Museum 👉 tacticsmd.net/congreso/cardi… Let’s connect, celebrate & inspire! #ESC2025 #cardiotox #ESCardioOnco26

The index QFR shows good diagnostic accuracy in identifying non-culprit intermediate lesions with positive FFR in a staged procedure, which may help avoid such staged procedures. Read this article published in REC Publications by josep ACI-SEC: Hemodinamica revespcardiol.org/en-diagnostic-…

Predictors of recurrent venous thromboembolism and bleeding in patients with cancer. Read the results of a meta-analysis published in #EHJ 👉 ow.ly/RYFZ50Wia88 Rocco Montone EHJ Editor-in-Chief

🫀Escenarios en los que la evidencia recomienda NO usar anticoagulantes directos orales (DOACs): JACC State-of-the-Art Review. DOI: 10.1016/j.jacc.2023.10.038. #Cardiología #MedicinaInterna

🚨SGLT2 inhibitors: more than glycemic control. New insights into their cardioprotective and anticancer potential in diabetic patients. 🔍Discover emerging hypotheses in a new editorial in #EHJPharmacotherapy ow.ly/6min50WiZLO EHJ-CVP Editor-in-Chief Felice Gragnano Mattia Galli

Reduced echo monitoring every 6 months is safe and feasible for low risk HER2+ BC patients, per #Anthony Yu et al. A key step toward evidence-based, risk-adapted monitoring. #CardioOnc #CTRCD JACC Journals Kazuhiro Sase dineshpmcc International Cardio-Oncology Society

Using Danish population-based registries, #JACCCardioOnc study found elevated long-term #CVrisk in cancer survivors post systemic therapy 🔹HF/cardiomyopathy (HR 1.08) 🔹#VTE (HR 1.50) 🔹#Myocarditis/pericarditis (HR 1.30) 🔹Kidney failure (HR 1.17) 🔗 jacc.org/doi/10.1016/j.…

New in #JACCCardioOnc: After hematopoietic stem cell transplant #HSCT, ~1 in 4 patients developed #POTS, and it was linked to: 🔹Exaggerated norepinephrine rise on standing 🔹Higher adrenergic receptor-modulating autoantibody activity 📖: jacc.org/doi/abs/10.101… AntonioAbbate

Black patients with #prostate cancer on androgen deprivation therapy face higher #MACE risk vs White patients, largely mediated by social vulnerability index, and particularly socioeconomic status. jacc.org/doi/10.1016/j.… #JACCCardioOnc #CardioOnc #SDOH Dir, Thalheimer Center, EiC, JACC CardioOnc Clyde Yancy, MD, MSc

Worse #CVD risk scores or cardiovascular health metrics predict greater cancer risk, despite heterogeneity in CVD risk metrics & cancer types, according to a study published in #JACCCardioOnc. Read the journal scan to learn more: bit.ly/3GCQUb1 #CardioOnc JACC Journals

Worse #CVD risk scores or CV health metrics predict greater cancer risk, despite heterogeneity in CVD risk metrics and cancer types. The association was particularly strong with lung and colorectal cancers. jacc.org/doi/10.1016/j.… #JACCCardioOnc #CardioOnc